What is the dose of propranolol (Immediate Release) for hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol Immediate-Release Dosing for Hypertension

For hypertension, start propranolol immediate-release at 80-160 mg daily divided into 2 doses, titrate to a maintenance dose of 120-160 mg daily, with a maximum of 640 mg daily if needed. 1

Initial Dosing Strategy

  • Begin with 80-160 mg daily divided into 2 doses (e.g., 40-80 mg twice daily at 8 AM and 8 PM) 1, 2
  • The twice-daily regimen maintains therapeutic efficacy equivalent to four-times-daily dosing while improving compliance 2
  • Once-daily dosing (80-320 mg as a single morning dose) is also effective for patients already controlled on divided doses, though some loss of antihypertensive control may occur at the end of the dosing interval 3, 4

Titration and Maintenance

  • Titrate up to 120-160 mg daily for maintenance based on blood pressure response 1
  • If inadequate response, doses can be increased up to 480 mg/day when combined with a thiazide diuretic, achieving control in over 80% of patients 5
  • Maximum dose is 640 mg daily if needed, though most patients respond to lower doses 1
  • Allow adequate time between dose adjustments to assess response

Mandatory Pre-Treatment Assessment

Before initiating propranolol, you must screen for absolute contraindications 1:

  • Second or third-degree heart block
  • Decompensated heart failure
  • Asthma or obstructive airway disease
  • Cardiogenic shock
  • Sinus node dysfunction without pacemaker

Perform baseline assessment including 1:

  • Heart rate and blood pressure measurement
  • Cardiovascular examination with auscultation
  • Screen for history of bronchospasm, diabetes, and concurrent medications affecting cardiac conduction

Monitoring Requirements

  • Baseline cardiovascular assessment is mandatory before starting therapy 1
  • Monitor for hypotension and bradycardia, especially during dose escalation 1
  • No routine vital sign monitoring required between appointments if the patient is stable and asymptomatic 1
  • Routine blood work (CBC, renal, liver, thyroid function) is not required in otherwise healthy adults 1
  • ECG and echocardiogram only needed in selected cases with cardiac concerns 1

Critical Safety Considerations

  • Never abruptly discontinue propranolol, especially after chronic use—taper gradually over several weeks to prevent rebound hypertension, tachycardia, or angina 1
  • Avoid routine combination with non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to increased risk of bradycardia and heart block 1
  • Propranolol may mask symptoms of hypoglycemia in diabetic patients 1
  • Elderly patients may require lower doses due to altered pharmacokinetics 1

Common Adverse Effects

Monitor for 1:

  • Fatigue
  • Bradycardia
  • Hypotension
  • Dizziness
  • Cold extremities
  • Potential worsening of heart failure

Combination Therapy

When propranolol alone is insufficient 5, 6:

  • Combine with a thiazide diuretic as the preferred approach, effective in over 80% of patients at doses up to 480 mg/day 5
  • Propranolol-hydralazine combination is more effective than either component alone, with typical doses of 80-160 mg propranolol combined with 25-100 mg hydralazine twice daily 6
  • The combination prevents hydralazine-induced tachycardia while enhancing blood pressure control 6

References

Guideline

Medication Transition from Flupentixol/Melitracen to Propranolol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antihypertensive efficacy of propranolol given twice daily.

Canadian Medical Association journal, 1979

Research

Once-daily propranolol for hypertension.

Drug intelligence & clinical pharmacy, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.